How Is Marker Therapeutics Inc. (MRKR)’s Price-To-Earnings Ratio?

As of Friday close, Marker Therapeutics Inc.’s (NASDAQ:MRKR) stock was up $0.21, moving up 63.64 percent to $0.54. The average number of shares traded per day over the past five days has been 16,613,061 shares. 5 times new highs have been achieved over the past 5 days, with a $0.2210 gain in that time frame. In the last twenty days, the average volume was 4,272,630, while in the previous 50 days, it was 1,894,852.

Since last month, MRKR stock rose 49.96%. Shares of the company fell to $0.2975 on 08/02/22, the lowest level in the past month. A 52-week high of $2.17 was reached on 01/03/22 after having rallying from a 52-week low of $0.25. Since the beginning of this year, MRKR’s stock price has dropped by -43.17% or -$0.4102, and marked a new high 1 time. However, the stock has declined by -75.12% since its 52-week high.


Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored


Valuation Metrics

The stock’s beta is 1.30. Besides these, the trailing price-to-sales (P/S) ratio of 20.70, the price-to-book (PB) ratio of 1.26.

Financial Health

In the three months ended March 30, Marker Therapeutics Inc.’s quick ratio stood at 3.80, while its current ratio was 3.80, showing that the company is able to pay off its debt. Based on annual data, MRKR earned $40.72 million in gross profit and brought in $1.24 million in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -95.20%. Return on equity (ROE) for the past 12 months was -88.10%.

MRKR’s revenue rose 100.0% to $1.24 million during the quarter, while net income inched up to $0.96 million. While analysts expected Marker Therapeutics Inc. to report -$0.13 quarterly earnings, the actual figure was -$0.12 per share, beating the consensus estimate by 7.70%. During the quarter, the company generated -$8.96 million in EBITDA. The liabilities of Marker Therapeutics Inc. were 19.25 million at the end of its most recent quarter ended March 30, and its total debt was $11.72 million. The value of shareholders’ equity is $83.6 million.

Technical Picture

This quick technical analysis looks at Marker Therapeutics Inc.’s (MRKR) price momentum. With a historical volatility rate of 247.64%, the RSI 9-day stood at 88.09% on 05 August.

With respect to its five-day moving average, the current Marker Therapeutics Inc. price is up by +69.28% percent or $0.2210. At present, MRKR shares trade +47.95% above its 20-day simple moving average and +28.57% percent above its 100-day simple moving average. However, the stock is currently trading approximately +59.91% above its SMA50 and -64.94% below its SMA200.

Stochastic coefficient K was 52.10% and Stochastic coefficient D was 37.52%, while ATR was 0.0629. Given the Stochastic reading of 66.90% for the 14-day period, the RSI (14) reading has been calculated as 81.78%. As of today, the MACD Oscillator reading stands at 0.0540, while the 14-day reading stands at 0.0538.

Analyst Ratings

Piper Sandler launched its rating on Marker Therapeutics Inc. (NASDAQ: MRKR) to an Overweight in a note to investors on March 25, 2021. Marker Therapeutics Inc. (MRKR) has been rated Overweight by analysts. According to 0 brokerage firms, MRKR is a sell, and 1 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Marker Therapeutics Inc. stock as buy, with 3 recommending it as overweight.

With a median target price of $2.75, the current consensus forecast for the stock is $1.00 – $5.00. Based on these forecasts, analysts predict Marker Therapeutics Inc. (MRKR) will achieve an average price target of $2.88.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Hot Topics

Related Articles

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]